TCM Biotech International Corp. (4169.TWO)

55.60 +0.40 (+0.72%) At close: 02:59PM CST

TCM Biotech International Corp.

B Building 24F-8, No.97, Sec. 1
Xintai 5th Road Xizhi District
Taipei 221416
Taiwan
886 2 2697 2628
https://www.tcmbio.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Ya-Chun Wang	President	N/A	N/A	N/A
Shu Ya Yang	Accounting Department Manager	N/A	N/A	N/A
Prof. Pei-Jer Chen M.D., MBBS, Ph.D.	Chief Advisor	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company's products include osteoarthritis treatment products, osteoporosis treatment preparations, iron supplement, urinary system treatment products, expectorants/mucolytic agents, anti-hypertensive preparations, and anti-diabetic preparations, anti-adhesion systems, pellefeel wound care systems, Philips non-invasive ventilators, and others, as well as medical devices and functional foods. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.

Corporate governance

TCM Biotech International Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.